Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients

Clinical trial NCT04362722 · UNKNOWN

Trial details

NCT number: NCT04362722
Sponsor: Philogen S.p.A.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Basal Cell Carcinoma, Cutaneous Squamous Cell

Start date: 2020-09-02
Primary completion: 2024-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.